Last reviewed · How we verify

NCT04980742

Perioperative Risk Factors of Outcomes for Cardiac Surgery: A Retrospective Study

Status unknown Last updated 28 July 2021
What this trial tests

trial testing acute normovolemic hemodilution in Post-cardiac Surgery in 3,000 participants. Status unknown.

Timeline
1 July 2017
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment3,000
Start date1 July 2017
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Who can join

18 and older, any sex, with Post-cardiac Surgery or Blood Transfusion Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Based on a review of about 10,000 patients undergoing cardiac surgery under CPB in West China Hospital of Sichuan University and the Second Affiliated Hospital of Zhejiang University, we try to evalute the effect of blood transfusion on outcomes in cardiac surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of acute normovolemic hemodilution

Trials testing the same drug.

Other recruiting trials for Post-cardiac Surgery

Currently open trials in the same condition.

Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04980742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing